99 related articles for article (PubMed ID: 31480)
1. Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings.
Humber LG; Sideridis N; Asselin AA; Bruderlein FT; Voith K
J Med Chem; 1978 Dec; 21(12):1225-31. PubMed ID: 31480
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues.
Voith K; Bruderlein FT; Humber LG
J Med Chem; 1978 Jul; 21(7):694-8. PubMed ID: 27637
[TBL] [Abstract][Full Text] [Related]
3. Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol.
Philipp AH; Humber LG; Voith K
J Med Chem; 1979 Jul; 22(7):768-73. PubMed ID: 571917
[TBL] [Abstract][Full Text] [Related]
4. Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamol.
Humber LG; Bruderlein FT; Philipp AH; Götz M
J Med Chem; 1979 Jul; 22(7):761-7. PubMed ID: 571916
[TBL] [Abstract][Full Text] [Related]
5. Use of the butaclamol template in a search for antipsychotic agents with lessened side effects.
Kukla MJ; Bloss JL; Brougham LR
J Med Chem; 1979 Apr; 22(4):401-6. PubMed ID: 34721
[TBL] [Abstract][Full Text] [Related]
6. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
Voith K; Herr F
Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
[TBL] [Abstract][Full Text] [Related]
7. Effects of chlorine substituents on the benzene rings of an analogue of the antipsychotic drug butaclamol on the interaction with dopamine and muscarinic receptors in rat brain.
Pugsley TA; Lippmann W
J Pharm Pharmacol; 1979 Jan; 31(1):47-9. PubMed ID: 32368
[No Abstract] [Full Text] [Related]
8. Behavioral studies on the enantiomers of butaclamol demonstrating absolute optical specificity for neuroleptic activity.
Voith K; Cummings JR
Can J Physiol Pharmacol; 1976 Aug; 54(4):551-60. PubMed ID: 10059
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological study of the thiophene analogue of taclamine, QM-7184, a new neuroleptic drug with potent alpha-adrenoceptor blocking activity.
Arribas E; Vega S; Benito C; Fernandez-Tome MP; del Rio J
Arzneimittelforschung; 1983; 33(10):1417-21. PubMed ID: 6140017
[TBL] [Abstract][Full Text] [Related]
10. Conformational properties of butaclamol and isobutaclamol. Regularities in the structures of semirigid neuroleptics.
Froimowitz M; Matthysse S
Mol Pharmacol; 1983 Sep; 24(2):243-50. PubMed ID: 6193405
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole derivatives and their central nervous system activities.
Nagai Y; Irie A; Masuda Y; Oka M; Uno H
J Med Chem; 1979 Jun; 22(6):677-83. PubMed ID: 37336
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and neuroleptic activity of benzamides. Cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide and related compounds.
Iwanami S; Takashima M; Hirata Y; Hasegawa O; Usuda S
J Med Chem; 1981 Oct; 24(10):1224-30. PubMed ID: 6120234
[TBL] [Abstract][Full Text] [Related]
13. 10-Piperazinyl-4H-theino[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as potential neuroleptics.
Chakrabarti JK; Fairhurst J; Gutteridge NJ; Horsman L; Pullar IA; Smith CW; Steggles DJ; Tupper DE; Wright FC
J Med Chem; 1980 Aug; 23(8):884-9. PubMed ID: 6105217
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds.
Bruderlein FT; Humber LG
J Med Chem; 1975 Feb; 18(2):185-8. PubMed ID: 1168258
[TBL] [Abstract][Full Text] [Related]
15. Direct effect of neuroleptics on glutamate release.
Sherman AD; Mott J
Neuropharmacology; 1984 Nov; 23(11):1253-9. PubMed ID: 6084822
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
17. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB
Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151
[TBL] [Abstract][Full Text] [Related]
18. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics.
Chakrabarti JK; Horsman L; Hotten TM; Pullar IA; Tupper DE; Wright FC
J Med Chem; 1980 Aug; 23(8):878-84. PubMed ID: 6105216
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological characterization of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents.
Yevich JP; New JS; Lobeck WG; Dextraze P; Bernstein E; Taylor DP; Yocca FD; Eison MS; Temple DL
J Med Chem; 1992 Nov; 35(24):4516-25. PubMed ID: 1361578
[TBL] [Abstract][Full Text] [Related]
20. [Effect of butaclamol enantiomers on hypothalamic tyrosine hydroxylase in the rat brain].
Mineeva MF; Raevskiĭ KS
Biull Eksp Biol Med; 1984 Oct; 98(10):453-6. PubMed ID: 6208950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
